Abstract:Xiaoou Li, 1 Wei Gao, 2 Zhonglan Jia, 3 Kaihu Yao, 2 Jinyan Yang, 1 Jingjing Tong, 4 Yajuan Wang 5 1 Department of Neonatology, Haidian District Maternal and Child Health Care Hospital, Beijing, 100080, People's Republic of China; 2 Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Laboratory of Dermatology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China; 3 Department of Clinical Laboratory, Haidian District Maternal and Child Health Care Hospital, Beijing, 100080, People's Republic of China; 4 Department of Neonatology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100026, People's Republic of China; 5 Department of Neonatology, Children's Hospital, Capital Institute of Pediatrics, Beijing, 100020, People's Republic of China Correspondence: Yajuan Wang, Department of Neonatology, Children's Hospital, Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, 100020, People's Republic of China, Tel +86-10-85695631, Email Purpose: We investigate the drug resistance, serotype and multilocus sequence typing (MLST) of Group B streptococcus (GBS) strains obtained from pregnant women and neonates in a hospital in Beijing. Patients and Methods: In this cross-sectional study, 1470 eligible pregnant women at a gestational age of 35– 37 weeks presented to our department between May 2015 and May 2016 were included. Vaginal and rectal samples from pregnant women together with sampling from neonatal samples were collected to screen GBS. GBS strains were subject to drug resistance and serotype analysis and MLST. Results: GBS strains were isolated from 111 pregnant women (7.6%) and 6 neonates (0.99%) from 606 matched neonates. 102 strains from pregnant women and 3 strains from neonates were included in the drug sensitivity test, serotyping and MLST typing. All these strains were susceptible to ampicillin, penicillin, ceftriaxone, vancomycin, linezolid, and meropenem. Sixty strains (58.8%) showed multi-drug resistance. Serious cross-resistance was seen between erythromycin and clindamycin. There were eight serotypes, and 37 strains (36.3%) showed a serotype of type III serving as the major type. All 102 GBS strains isolated from pregnant samples could be divided into 18 STs types. They belonged to five clonal complexes and five single clones, with the predominant type of ST19/III, ST10/Ib, and ST23/Ia, with CC19 as the most common type. Three GBS strains isolated from neonates covered two serotypes (ie type III and Ia) that were consistent with those of the mothers. Conclusion: Serotype III was the predominant serotype of GBS in this study. The predominant MLST type was ST19, ST10, and ST23, with ST19/III, ST10/Ib, and ST23/Ia serving as the most prevalent and CC19 as the most common clonal complex. GBS strains from neonates were consistent in the clonal complex, serotype, and MLST with these isolated from the mothers. Keywords: Group B streptococcus, multilocus sequence typing, drug resistance, molecular epidemiology Group B streptococcus (GBS), a gram-positive bacterium commonly colonized in the gastrointestinal and genitourinary tracts, is the leading cause of serious neonatal infection. 1 According to the CDC guidelines, GBS screening is recommended at a gestational age of 35–37 weeks, and most GBS infection can be prevented using universal screening followed by intrapartum antimicrobial prophylaxis (IAP). 2 The utilization of IAP reduces the incidence of early onset GBS disease (GBS-EOD) significantly, but antibiotics may also trigger infection of drug-resistant strains. Penicillin has been preferred for the prevention and treatment of GBS infection as GBS strains are susceptible to penicillin. 3 However, there are few studies reporting decreased susceptibility to penicillin. 4,5 Indeed, the application of antibiotics triggers significant decline in the postnatal infection and neonatal diseases, together with the incidence of severe conditions and even mortality, but it may increase the risk of drug resistance and dissemination. Meanwhile, a high proportion of GBS is resistant to erythromycin, clindamycin, tetracycline, and quinolones, which raises a challenge for the management of GBS infection. 6 In mainland China, the colonization rate of GBS varies in different geographic locations, and there is no exact consensus on the GBS screening in China. In a recent study, the GBS colonization rate in C -Abstract Truncated-

Genomic Analysis of Maternal Carriage of Group B Streptococcus and Transmission Routes of Neonatal Sepsis.

Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

[Rapid Group B Streptococcus Screening Methods in Late Pregnancy and the Maternal-Neonatal Outcomes].

Burden and risk factors of invasive group B Streptococcus disease among neonates in a Chinese maternity hospital

Neonatal Early-Onset Blood Stream Infection Caused by Group B Streptococcus: Analysis of 55 Cases

Transmission of Group B Streptococcus in late-onset neonatal disease: a narrative review of current evidence

Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses

Characterization of Group B Streptococcus Recovered from Pregnant Women and Newborns Attending in a Hospital in Beijing, China

Risk Factors and Drug Resistance in Early-Onset Neonatal Group B Streptococcal Disease.

Complicated Streptococcus agalactiae Sepsis with/without Meningitis in Young Infants and Newborns: The Clinical and Molecular Characteristics and Outcomes

Clinical and Laboratory Features of Group B Streptococcus Meningitis in Infants and Newborns: Study of 848 Cases in France, 2001–2014

Molecular Epidemiology of Group B Streptococcus Isolates from Pregnant Women with Premature Rupture of Membranes in Fuzhou, China

Late Onset Streptococcus agalactiae Meningitis following Early Onset Septicemia: A Preventable Disease?

Clinical Analysis of 30 Cases of Neonatal Group B Streptococcus Sepsis

Genomic Analysis of Group B Streptococcus from Neonatal Sepsis Reveals CC17 Clonal Expansion and Insights into Virulence- and Resistance-Associated Traits After Intrapartum Antibiotic Prophylaxis

The Clinical and Genetic Characteristics of Streptococcus agalactiae Meningitis in Neonates

Clinical and Molecular Epidemiology of Invasive Group B Streptococcus Disease among Infants, China.

Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses

Molecular evidence that GBS early neonatal sepsis results from ascending infection: comparative hybrid genomics analyses show that microorganisms in the vaginal ecosystem, amniotic fluid, chorioamniotic membranes, and neonatal blood are the same

The Risk Factors for Group B Streptococcus Colonization During Pregnancy and Influences of Intrapartum Antibiotic Prophylaxis on Maternal and Neonatal Outcomes

Effects of group B streptococcus infection on vaginal micro-ecology and pregnancy outcomes of pregnant women in late pregnancy